| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |